Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market

May 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market...

Reportlinker Adds Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

May 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management...

All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated

May 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., May 26, 2011 /- Pharmasset, Inc. (Nasdaq: VRUS ) announced today the initiation of a Phase 2a trial investigating the combination of Pharmasset's PSI-7977, a nucleotide polymerase inhibitor, and BMS-790052, Bristol-Myers Squibb Company's (NYSE: BMY ) NS5A replication...

Advertisement

Reportlinker Adds Advances in Drug-Diagnostic Co-Development

May 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Advances in Drug-Diagnostic Co-Development...

Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook

May 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Specialty Pharmaceutical Industry - 2011 Yearbook...

Reportlinker Adds The Infusion Pump Market Outlook to 2016

May 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Infusion Pump Market Outlook to 2016...

Verisante Technology Inc. Joins OTCQX

May 26, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- OTC Markets Group Inc. (OTCQX: OTCM), the financial information and technology services company that provides the world's largest electronic marketplace for broker-dealers to trade unlisted stocks, today announced that Verisante Technology Inc. (TSX.V: VRS;...

Winner Medical Appoints New Independent Director

May 26, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, May 26, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical" or "the Company"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced...

Advertisement

Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016

May 26, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Drug-Eluting Stent Market Outlook to 2016...

Reportlinker Adds Global: Pharmaceuticals Industry Guide

May 26, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global: Pharmaceuticals Industry Guide...

Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals' Lorcaserin Achieved Statistically Significant Weight Loss

May 26, 2011 2:31 am | by Bio-Medicine.Org | News | Comments

ISTANBUL, May 26, 2011 /- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today presented meta-analyses of the three trials in the lorcaserin Phase 3 clinical trial program at ECO 2011, the 18th European Congress on Obesity. The analyses show that lorcaserin caused statistically significant...

Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly

May 25, 2011 10:32 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 26, 2011 /- Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN ) ("Amylin" or "the Company") today announced that the United States District Court for the Southern District of California issued a temporary restraining order (TRO) against Eli Lilly and Company (NYSE: LLY ) ("Lilly")...

Sutter Health Joins Health Systems Nationwide to Share and Compare Data on Quality, Outcomes and Cost

May 25, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

SACRAMENTO, Calif., May 25, 2011 /- Sutter Health joins more than a dozen nationally-recognized health systems in the High Value Healthcare Collaborative (HVHC) – a project that will share comparative data to glean new ways to improve clinical outcomes while reducing health care...

Advertisement

Bayer's Discrimination Lawsuit Now Requires Extra-Strength Cure

May 25, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

NEWARK, N.J., May 25, 2011 /- Just days after the one year anniversary of winning a $250 million verdict for female sales representatives at Novartis Pharmaceuticals Corporation, the law firm of Sanford Wittels & Heisler LLP filed a nearly identical class action on behalf of female...

Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC

May 25, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn., May 25 /- Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology (ASCO) annual meeting in Chicago (June 3-7) that indicates combining its investigational therapy afatinib (BIBW 2992) with cetuximab at...

Cyberonics to Participate in 2011 Jefferies Global Healthcare Conference

May 25, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

HOUSTON, May 25, 2011 /- Cyberonics, Inc. (NASDAQ: CYBX ), a global leader in epilepsy management, today announced it will participate in the 2011 Jefferies Global Healthcare Conference on Wednesday, June 8, 2011, in New York. Greg Browne, Cyberonics' Senior Vice President, Finance &...

Why Don't Elderly People Follow Doctors Orders for Medications? 55% of Prescriptions Filled Aren't Taken Correctly

May 25, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

NAPLES, Fla., May 25, 2011 /- A common question asked by people taking care of elderly parents is: "Is it dangerous if mom forgets to take her medication, or splits pills to save money?" Not taking medications properly can be extremely dangerous. More than 125,000 people die each year due...

Spa & Resort/Medical Aesthetics Expo Platforms Unique Exhibitor Offerings

May 25, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 25, 2011 /- Spa & Resort/Medical Aesthetics Expo will feature new innovations that will enhance client offerings for spa and salon owners.  These new products will be displayed and demonstrated at the event taking place June 28-29 at the Jacob K. Javits Convention...

FUJIFILM's FDR D-EVOâ„¢ Wireless Now Available in the U.S.

May 25, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., May 25, 2011 /- FUJIFILM Medical Systems U.S.A., Inc. is pleased to announce the FDA 510(k) clearance and commercial availability of the FDR D-EVO™ Wireless. This new wireless version of the company's flat panel detector will deliver Fujifilm's renowned image...

Graymark Announces 1-for-4 Reverse Stock Split

May 25, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

OKLAHOMA CITY, May 25, 2011 /- Graymark Healthcare, Inc. (NASDAQ: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), reported that its Board of Directors approved a 1-for-4 reverse stock...

Quad-Channel 16-bit, 100 MSPS ADC for Faster, Smaller Medical Imaging Equipment

May 25, 2011 6:29 am | Product Releases | Comments

Texas Instruments Incorporated today introduced the first quad-channel, 16-bit analog-to-digital converter (ADC) for medical imaging applications, such as magnetic resonance imaging (MRI).

Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug

May 25, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif. and LONDON, May 25, 2011 /- Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm – have partnered with Centella Therapeutics, Inc. of Palo Alto, California, to develop, manufacture and trial a promising new drug,...

Mylan Launches Generic Version of Roxicodone® Tablets

May 25, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 25, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone Hydrochloride (HCI) Tablets USP, 5 mg, 15 mg and 30 mg, based on a development and supply agreement with Coastal Pharmaceuticals. This product is the...

XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System

May 25, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 25, 2011 /- XDATA retains Adapt IP Ventures to market XDATA's intellectual property including patents and fully-functioning prototype focused on breast cancer detection. Over many decades, XDATA has developed, patented and tested methods and devices for automatically...

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

May 25, 2011 3:33 am | by Boston Scientific | News | Comments

Boston Scientific becomes the first and only company to offer two distinct drug-eluting stents to treat small vessels

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading